Target type: biologicalprocess
The chemical reactions and pathways resulting in the formation of a triglyceride, any triester of glycerol. [ISBN:0198506732]
The triglyceride biosynthetic process is a complex pathway that involves the synthesis of triglycerides, which are the primary form of fat storage in the body. Triglycerides are composed of three fatty acids esterified to a glycerol molecule. The synthesis of triglycerides occurs primarily in the liver and adipose tissue.
The process begins with the activation of fatty acids, which are converted to fatty acyl-CoAs. These activated fatty acids then enter the endoplasmic reticulum (ER), where they are incorporated into triglycerides. The synthesis of triglycerides involves two key enzymes: glycerol-3-phosphate acyltransferase (GPAT) and diacylglycerol acyltransferase (DGAT).
GPAT catalyzes the first step in the synthesis of triglycerides, the attachment of a fatty acid to glycerol-3-phosphate. This reaction forms lysophosphatidic acid (LPA). The second step involves the attachment of a second fatty acid to LPA, forming phosphatidic acid (PA). PA is then dephosphorylated by a phosphatase to form diacylglycerol (DAG).
DGAT then catalyzes the final step in the synthesis of triglycerides, the attachment of a third fatty acid to DAG. The resulting triglyceride molecule can then be packaged into very low-density lipoprotein (VLDL) particles in the liver or stored in adipose tissue.
The regulation of triglyceride biosynthesis is complex and involves a variety of factors, including dietary intake, hormonal signals, and cellular energy status. For example, insulin promotes the synthesis of triglycerides, while glucagon and epinephrine inhibit the process.
Triglyceride biosynthesis is essential for energy storage and the regulation of lipid metabolism. Dysregulation of this pathway can lead to a number of health problems, including obesity, hyperlipidemia, and cardiovascular disease.'
"
Protein | Definition | Taxonomy |
---|---|---|
Diacylglycerol O-acyltransferase 2 | A diacylglycerol O-acyltransferase 2 that is encoded in the genome of human. [PRO:DNx, UniProtKB:Q96PD7] | Homo sapiens (human) |
Dihydroxyacetone phosphate acyltransferase | A dihydroxyacetone phosphate acyltransferase that is encoded in the genome of human. [PRO:DNx, UniProtKB:O15228] | Homo sapiens (human) |
Diacylglycerol O-acyltransferase 2 | A diacylglycerol O-acyltransferase 2 that is encoded in the genome of human. [PRO:DNx, UniProtKB:Q96PD7] | Homo sapiens (human) |
Diacylglycerol O-acyltransferase 1 | A diacylglycerol O-acyltransferase 1 that is encoded in the genome of human. [PRO:DNx, UniProtKB:O75907] | Homo sapiens (human) |
Diacylglycerol O-acyltransferase 1 | A diacylglycerol O-acyltransferase 1 that is encoded in the genome of human. [PRO:DNx, UniProtKB:O75907] | Homo sapiens (human) |
1-acyl-sn-glycerol-3-phosphate acyltransferase beta | A 1-acyl-sn-glycerol-3-phosphate acyltransferase beta that is encoded in the genome of human. [PRO:DNx, UniProtKB:O15120] | Homo sapiens (human) |
Compound | Definition | Classes | Roles |
---|---|---|---|
chloramphenicol | Amphenicol: Chloramphenicol and its derivatives. | C-nitro compound; carboxamide; diol; organochlorine compound | antibacterial drug; antimicrobial agent; Escherichia coli metabolite; geroprotector; Mycoplasma genitalium metabolite; protein synthesis inhibitor |
carbenicillin | carbenicillin : A penicillin antibiotic having a 6beta-2-carboxy-2-phenylacetamido side-chain. Carbenicillin: Broad-spectrum semisynthetic penicillin derivative used parenterally. It is susceptible to gastric juice and penicillinase and may damage platelet function. | penicillin; penicillin allergen | antibacterial drug |
nsc 674495 | NSC 674495: structure in first source | ||
ct-32228 | CT-32228: CT-32212 is the inactive isomer of CT-32228 used as a control; structure in first source | ||
azd3988 | AZD3988: for treatment of obesity and diabetes; structure in first source | ||
a-922500 | aromatic ketone | ||
azd7687 | AZD7687: structure in first source | ||
pf-04620110 | PF-04620110: a DGAT1 inhibitor; structure in first source | ||
pradigastat | |||
tetracycline | tetracycline : A broad-spectrum polyketide antibiotic produced by the Streptomyces genus of actinobacteria. Tetracycline: A naphthacene antibiotic that inhibits AMINO ACYL TRNA binding during protein synthesis. | ||
pf-06424439 | PF-06424439: an inhibitor of diacylglycerol acyltransferase 2; structure in first source |